Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS | Zendy

Louis-Philippe Laurin | Zendy; Adil Gasim | Zendy; Caroline J. Poulton | Zendy; Susan L. Hogan | Zendy; J. Charles Jennette | Zendy; Ronald J. Falk | Zendy; Bethany J. Foster | Zendy; Patrick H. Nachman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS

Author(s) -

Louis-Philippe Laurin,

Adil Gasim,

Caroline J. Poulton,

Susan L. Hogan,

J. Charles Jennette,

Ronald J. Falk,

Bethany J. Foster,

Patrick H. Nachman

Publication year - 2016

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07110615

Subject(s) - calcineurin , medicine , hazard ratio , immunosuppression , confidence interval , proportional hazards model , urology , prednisone , transplantation

In primary FSGS, calcineurin inhibitors have primarily been studied in patients deemed resistant to glucocorticoid therapy. Few data are available about their use early in the treatment of FSGS. We sought to estimate the association between choice of therapy and ESRD in primary FSGS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research